FDA Clears Adjunctive Lung Ventilation Software for CT
With algorithms utilized in aerospace technology, the CT LVAS software reportedly provides enhanced assessment of regional airflow and lung ventilation.
The Food and Drug Administration (FDA) has granted 510(k) clearance for CT LVAS, an adjunctive software that provides detailed analysis of lung ventilation based on computed tomography (CT) scans.
Offering color-coded images of regional airflow and lung ventilation that are overlayed on CT scans, the CT LVAS provides quantifiable assessments of lung volume change and regional lung ventilation heterogeneity, according to 4DMedical, the developer of CT LVAS.
The company said the CT LVAS facilitates regional lung ventilation measurement in thousands of locations in the lungs.
“Having assisted with image interpretation of CT LVAS exams in Australia, I've seen the diagnostic power of adding functional assessment to the structural information provided in standard non-contrast chest CTs,” noted Greg Mogel, M.D., a consultant radiologist at 4DMedical. “CT LVAS allows radiologists to provide a whole new dimension of lung health information to referring clinicians needing answers.”
4DMedical added that the combination of CT LVAS with a forthcoming CT:VQ software, which provides quantitative perfusion assessment based on CT scans, may enhance the diagnosis of pulmonary embolism and assessment of conditions such as chronic obstructive pulmonary disease (COPD).
Recent Videos
Related Content
GE HealthCare Debuts AI-Powered Cardiac CT Device at ACC Conference
April 1st 2025Article
Featuring enhanced low-dose image quality with motion-free images, the Revolution Vibe CT system reportedly facilitates improved diagnostic clarity for patients with conditions ranging from in-stent restenosis to atrial fibrillation.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020Podcast
In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can Photon-Counting CT be an Alternative to MRI for Assessing Liver Fat Fraction?
March 21st 2025Article
Photon-counting CT fat fraction evaluation offered a maximum sensitivity of 81 percent for detecting steatosis and had a 91 percent ICC agreement with MRI proton density fat fraction assessment, according to new prospective research.
